Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.35%
Period
EPS Actual
EPS Est
Surprise
March 31, 2026
$-0.51
$-0.19
-0.32%
Dec. 31, 2025
$-0.67
$-0.16
-0.51%
Sept. 30, 2025
$-0.37
$-0.15
-0.22%
June 30, 2025
$-0.35
$-0.20
-0.15%
March 31, 2025
$-0.38
$-0.24
-0.14%
Dec. 31, 2024
$-1.02
$-0.25
-0.77%
Peer comparison (GICS sub-industry)
Key metrics vs sector peers
Ticker
Market Cap
P/E
Rev YoY
Net Margin
ROE
Gross Margin
SURG
$35M
-0.9
-6.4%
-63.3%
227162.6%
—
SPOK
$272M
17.6
1.5%
11.4%
10.7%
—
TMUS
—
—
—
—
—
—
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
Income Statement17
Annual Income Statement data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$57M
$61M
$137M
$122M
$51M
$54M
$26M
$15M
$13M
$3M
$3M
·
Cost of Revenue
$68M
$75M
$101M
$108M
$45M
$52M
$23M
$9M
$8M
$2M
$2M
·
Gross Profit
·
·
·
·
·
$2M
$3M
$7M
$5M
$968.3K
$500.7K
·
SG&A Expense
$20M
$27M
$17M
$13M
$12M
$13M
$11M
$8M
$5M
$3M
$1M
·
Operating Expenses
$20M
$27M
$17M
$13M
$12M
$13M
$11M
$8M
$5M
$4M
$2M
·
Operating Income
$-34M
$-43M
$19M
$633.8K
$-6M
$-10M
$-8M
$-2M
$204.3K
$-3M
$-1M
·
Interest Expense
·
·
·
$400.0K
·
·
·
·
·
·
$15.2K
·
Interest Income
$64.0K
$105.4K
·
·
·
·
·
·
·
·
·
·
Other Non-op
$-2M
$396.2K
$-485.8K
$-1M
$-8M
$-576.0K
$-679.0K
$76.6K
$3M
$-1M
$-15.1K
·
Pretax Income
$-36M
$-43M
$18M
$-553.2K
·
$-11M
$-8M
$-1M
$3M
$-5M
$-1M
·
Income Tax
·
$3M
$-2M
·
·
·
·
$82.2K
·
·
·
·
Net Income
$-36M
$-46M
$21M
$-680.8K
$-14M
$-11M
$-8M
$-2M
$3M
$-5M
$-1M
·
EPS (Basic)
$-1.80
$-2.39
$1.45
$-0.05
$-3.09
·
·
·
·
·
·
·
EPS (Diluted)
$-1.80
$-2.39
$1.38
$-0.05
·
·
·
·
·
·
·
·
Shares (Basic)
20,085,138
19,119,181
14,258,172
12,395,364
4,381,709
·
·
·
·
·
·
·
Shares (Diluted)
20,085,138
19,119,181
14,922,881
12,395,364
·
·
·
·
·
·
·
·
EBITDA
$-34M
$-42M
$19M
$633.8K
$-5M
$-9M
$-8M
$-1M
$-2M
$-3M
$-819.9K
·
Balance Sheet26
Annual Balance Sheet data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$2M
$12M
$15M
$7M
$6M
$674.0K
$346.0K
$444.6K
$1M
$439.3K
$69.5K
$37.8K
Receivables
$4M
$3M
$10M
$9M
$3M
$180.5K
$3M
$206.7K
$5.5K
$126.4K
$275.1K
$281.7K
Inventory
$339.6K
$2M
$9M
$11M
$4M
$178.3K
·
·
·
·
·
·
Prepaid Expense
$581.8K
$298.4K
$161.9K
$111.5K
·
$5.6K
$96.9K
$10.9K
·
$568.7K
$1.5K
$4.5K
Current Assets
$7M
$18M
$33M
$28M
$14M
$1M
$4M
$3M
$3M
$758.8K
$346.0K
$323.9K
PP&E (Net)
$403.5K
$591.1K
$361.8K
$643.4K
$200.4K
$236.8K
$294.6K
$31.0K
$26.0K
$14.4K
$14.4K
$4.6K
PP&E (Gross)
$2M
$2M
$1M
$1M
$366.2K
$342.3K
$335.7K
$48.8K
$153.0K
$19.1K
·
·
Accum. Depreciation
$1M
$1M
$727.2K
$445.7K
$165.8K
$105.5K
$38.7K
$13.8K
$127.0K
$4.7K
$1.7K
$19
Goodwill
·
$3M
$2M
$2M
$866.8K
$866.8K
$866.8K
$866.8K
·
$866.8K
·
·
Intangibles
$819.2K
$1M
$2M
$3M
$3M
$4M
$5M
$65.3K
·
$217.2K
$2M
$1M
Other Non-current Assets
·
·
·
·
·
$61.5K
$66.5K
$61.5K
·
·
·
·
Total Assets
$9M
$24M
$42M
$34M
$20M
$7M
$10M
$4M
$3M
$2M
$3M
$1M
Accounts Payable
·
·
·
$6M
$7M
$7M
$4M
$3M
$334.9K
$775.6K
$355.6K
$138.3K
Short-term Debt
·
·
·
$2M
$126.4K
·
$736.2K
·
·
·
·
·
Current Liabilities
$18M
$6M
$13M
$23M
$10M
$16M
$7M
$5M
$3M
$4M
$3M
$635.3K
Capital Leases
$99.2K
$319.2K
$356.3K
$399.4K
$438.9K
$155.2K
$119.9K
·
·
·
·
·
Total Liabilities
$24M
$9M
$14M
$29M
$16M
$18M
$15M
$6M
$4M
$4M
$3M
$1M
Long-term Debt
$15M
$4M
$5M
$8M
·
$8M
$9M
$1M
·
$2M
$2M
$794.9K
Total Debt
·
·
·
·
$126.4K
$3M
$3M
$1M
$790.2K
$2M
$2M
·
Common Stock
$21.9K
$20.4K
$14.4K
$14.1K
$12.1K
$2.5K
$102.2K
$88.0K
$152.6K
$57.3K
$36.1K
$28.0K
Paid-in Capital
$83M
$77M
$43M
$41M
$39M
$11M
$6M
$333.6K
$-155.6K
$4M
$784.9K
$12.0K
Retained Earnings
$-97M
$-61M
$-15M
$-36M
$-35M
$-22M
$-11M
$-2M
$-617.2K
$-6M
$-1M
$-6.9K
Treasury Stock
$2M
$632.0K
·
·
·
·
·
·
$1M
·
·
·
Stockholders' Equity
$-15M
$15M
$28M
$5M
$4M
$-11M
$-5M
$-2M
$-617.2K
$-3M
$-606.7K
$33.1K
Liabilities + Equity
$9M
$24M
$42M
$34M
$20M
$7M
$10M
$4M
$3M
$2M
$3M
$1M
Shares Outstanding
21,151,974
20,068,929
14,403,261
14,116,832
12,063,834
2,542,624
102,193,579
88,046,391
152,555,416
57,343,901
36,130,432
28,000,000
Cash Flow15
Annual Cash Flow data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
D&A
$206.2K
$942.5K
$935.0K
$933.4K
$759.4K
$1M
$227.3K
$149.6K
$6.9K
$433.1K
$501.1K
·
Stock-based Comp
$2M
$2M
$613.8K
$37.2K
$3.6K
$183.0K
$329.6K
$157.9K
·
·
$588.3K
·
Amort. of Intangibles
$653.8K
$653.5K
$653.5K
$653.5K
$692.3K
$1M
$200.0K
·
$115.3K
$430.1K
$499.4K
·
Other Non-cash
$13M
·
·
·
$-3M
$5M
$1M
$217.9K
$1M
$4M
$22.2K
·
Operating Cash Flow
$-21M
$-21M
$10M
$793.3K
$-15M
$-4M
$-7M
$-1M
$227.8K
$-641.9K
$-224.5K
·
CapEx
$18.6K
$518.2K
·
$11.4K
$51.4K
$6.6K
$227.6K
$331.8K
·
$3.0K
$9.7K
·
Investing Cash Flow
$-18.6K
$-3M
$-281.3K
$-1M
$-376.7K
$8.4K
$-32.2K
$-278.0K
·
$-503.0K
$18.3K
·
Net Debt Issued
$-11.1K
$-10.9K
$-14.3K
·
·
·
·
·
·
·
·
·
Stock Issued
$2M
$17M
·
·
·
·
·
·
·
·
·
·
Stock Repurchased
·
·
·
·
·
$500.0K
·
·
·
·
·
·
Net Stock Activity
$2M
$17M
·
·
·
$-500.0K
·
·
·
·
·
·
Financing Cash Flow
$11M
$22M
$-2M
$1M
$21M
$5M
$6M
$464.1K
$607.1K
$1M
$237.9K
·
Net Change in Cash
$-11M
$-2M
$8M
$752.2K
$6M
$328.0K
$-98.6K
$-829.5K
$834.9K
$-5.8K
$31.7K
·
Taxes Paid
·
·
·
·
·
·
·
$82.2K
·
·
·
·
Free Cash Flow
$-21M
$-22M
·
$781.9K
$-15M
$-4M
$-7M
$-1M
$-751.1K
$-644.9K
$-234.3K
·
Profitability8
Annual Profitability data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
·
·
·
·
·
4.5%
21.1%
43.8%
48.7%
29.4%
17.7%
·
Operating Margin
-59.9%
-68.6%
13.8%
0.52%
-11.7%
-18.6%
-30.2%
-10.1%
-144.7%
-94.2%
-46.6%
·
Net Margin
-63.3%
-75.1%
15.0%
-0.56%
-26.5%
-19.7%
-32.8%
-10.1%
-138.5%
-139.5%
-47.2%
·
Pretax Margin
-63.3%
-70.7%
13.4%
·
·
-19.7%
-32.8%
-9.6%
-138.5%
-139.5%
·
·
EBITDA Margin
-59.6%
-68.6%
13.8%
0.52%
-10.2%
-16.5%
-29.3%
-9.1%
-136.4%
-81.1%
-28.9%
·
ROA
-222.0%
-138.8%
54.3%
-2.5%
-100.9%
-123.9%
-120.1%
-43.0%
-72.0%
-184.6%
-65.3%
·
ROE
227162.6%
-209.9%
124.1%
-15.9%
468.2%
109.2%
264.6%
51.0%
142.8%
379.9%
465.8%
·
ROIC
·
-291.0%
75.0%
·
·
·
·
223.5%
·
·
·
·
Liquidity & Solvency5
Annual Liquidity & Solvency data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
0.4
2.9
2.6
1.2
1.4
0.1
0.5
0.6
0.1
0.2
0.1
·
Quick Ratio
0.3
2.4
1.9
0.7
1.0
0.1
0.5
0.1
0.1
0.0
0.1
·
Debt / Equity
·
·
·
·
0.0
-0.3
-0.6
-0.6
1.3
-1.0
-2.7
·
LT Debt / Equity
·
·
·
·
·
-0.1
-0.5
-0.3
0.1
-0.0
-0.9
·
Interest Coverage
·
·
·
1.6
·
·
·
·
·
·
-86.9
·
Efficiency3
Annual Efficiency data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
3.5
1.8
3.6
4.5
3.8
6.3
3.7
4.3
0.5
1.3
1.4
·
Inventory Turnover
63.7
13.9
10.0
13.9
19.8
582.6
·
·
·
·
·
·
Receivables Turnover
16.2
9.7
14.6
19.5
29.8
33.6
15.8
143.7
15.7
16.4
10.2
·
Per Share5
Annual Per Share data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$-0.73
$0.76
$1.96
$0.35
$0.29
$-0.08
$-0.05
$-0.02
$0.01
$-0.03
$-0.02
·
Revenue / Share
$2.84
$3.18
$9.19
·
·
·
·
·
·
·
·
·
Cash Flow / Share
$-1.06
$-1.11
$0.69
·
·
·
·
·
·
·
·
·
Cash / Share
$0.08
$0.59
$1.02
$0.50
$0.52
$0.01
$0.00
$0.01
$0.00
$0.00
$0.00
·
EPS (TTM)
$-1.80
$-2.39
$1.38
$-0.05
·
·
·
·
·
·
·
·
Growth Rates3
Annual Growth Rates data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
-6.4%
-55.6%
12.8%
138.0%
-6.2%
·
·
·
·
·
·
·
Revenue CAGR 3Y
-22.3%
6.0%
36.1%
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
0.92%
·
·
·
·
·
·
·
·
·
·
·
Valuation (TTM)14
Annual Valuation (TTM) data for SURG
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$57M
$61M
$137M
$122M
$51M
$54M
$26M
$15M
$13M
$3M
$3M
·
Net Income TTM
$-36M
$-46M
$21M
$-680.8K
$-14M
$-11M
$-8M
$-2M
$3M
$-5M
$-1M
·
Market Cap
$35M
$36M
$93M
$93M
$24M
$750M
$1.53B
$1.67B
·
·
·
·
Enterprise Value
·
·
·
·
$18M
$753M
$1.54B
$1.67B
·
·
·
·
P/E
-0.9
-0.7
4.7
-131.2
·
·
·
·
·
·
·
·
P/S
0.6
0.6
0.7
0.8
0.5
13.8
59.5
109.7
·
·
·
·
P/B
-2.3
2.3
3.3
18.6
6.9
-69.9
-326.2
-841.4
·
·
·
·
P / Tangible Book
·
3.4
3.8
170.2
·
·
·
·
·
·
·
·
P / Cash Flow
-1.7
-1.7
9.0
116.7
-1.6
-173.4
-234.6
-1647.2
·
·
·
·
P / FCF
-1.7
-1.6
·
118.4
-1.6
-173.1
-226.7
-1241.5
·
·
·
·
EV / EBITDA
·
·
·
·
-3.5
-83.9
-203.6
-1207.7
·
·
·
·
EV / FCF
·
·
·
·
-1.2
-173.8
-227.1
-1242.2
·
·
·
·
EV / Revenue
·
·
·
·
0.4
13.8
59.6
109.8
·
·
·
·
Earnings Yield
-107.8%
-134.3%
21.4%
-0.76%
·
·
·
·
·
·
·
·
Income Statement16
Quarterly Income Statement data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Revenue
$16M
$16M
$19M
$12M
$11M
$10M
$5M
$15M
$31M
$32M
$34M
$36M
$35M
$36M
$36M
$28M
Cost of Revenue
$24M
$19M
$21M
$14M
$14M
$21M
$13M
$19M
$23M
$25M
$24M
$26M
$27M
$30M
$34M
$26M
SG&A Expense
$4M
$7M
$4M
$4M
$5M
$7M
$6M
$7M
$6M
$7M
$3M
$4M
$3M
$3M
$3M
$3M
Operating Expenses
$4M
$7M
$4M
$4M
$5M
$7M
$6M
$7M
$6M
$7M
$3M
$4M
$3M
$3M
$3M
$3M
Operating Income
$-11M
$-13M
$-7M
$-7M
$-8M
$-20M
$-14M
$-11M
$2M
$866.2K
$7M
$6M
$5M
$4M
$-1M
$-847.5K
Interest Expense
·
·
·
·
·
·
·
·
·
·
·
$0
$400.0K
·
·
·
Interest Income
·
$37
·
$7.0K
$56.9K
$-78.1K
$183.5K
·
·
·
·
·
·
·
·
·
Other Non-op
$-851.7K
$-1M
$-539.2K
$-272.3K
$-55.4K
$-26.2K
$1.0K
$537.9K
$-116.4K
$-102.5K
$-78.4K
$-145.6K
$-159.3K
$-203.8K
$-744.0K
$-44.4K
Pretax Income
$-12M
$-14M
$-7M
$-7M
$-8M
$-20M
$-14M
$-10M
$2M
$763.8K
$7M
$6M
$5M
·
·
·
Income Tax
·
·
·
·
·
$-100.0K
·
$3M
$423.0K
·
·
·
·
·
·
·
Net Income
$-12M
$-14M
$-7M
$-7M
$-8M
$-20M
$-14M
$-13M
$1M
$3M
$7M
$6M
$5M
$3M
$-2M
$-973.0K
EPS (Basic)
$-0.51
$-0.68
$-0.38
$-0.36
$-0.38
$-1.07
$-0.73
$-0.66
$0.07
$0.21
$0.50
$0.42
$0.32
$0.25
$-0.12
$-0.08
EPS (Diluted)
$-0.51
$-0.68
$-0.38
$-0.36
$-0.38
$-1.07
$-0.73
$-0.66
$0.07
$0.18
$0.49
$0.40
$0.31
$0.25
$-0.12
$-0.08
Shares (Basic)
23,703,775
-39,712,392
19,839,159
19,889,442
20,068,929
-37,694,661
19,689,010
19,431,549
17,693,283
-28,355,450
14,291,263
14,191,083
14,131,276
-24,380,191
12,443,052
12,268,669
Shares (Diluted)
23,703,775
-39,712,392
19,839,159
19,889,442
20,068,929
-38,679,514
19,689,010
19,431,549
18,678,136
-29,196,791
14,507,984
15,076,466
14,535,222
-24,380,191
12,443,052
12,268,669
EBITDA
$-11M
·
$-7M
$-7M
$-7M
·
$-14M
$-11M
$2M
·
$7M
$6M
$5M
·
$-1M
$-847.5K
Balance Sheet26
Quarterly Balance Sheet data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Cash & Equivalents
$2M
$2M
$3M
$4M
$5M
$12M
$14M
$38M
$43M
$15M
$13M
$5M
$9M
$7M
$8M
$9M
Short-term Investments
·
·
·
·
·
·
$10M
·
·
·
·
·
·
·
·
·
Receivables
$5M
$4M
$4M
$3M
$2M
$3M
$2M
$1M
$8M
$10M
$10M
$10M
$10M
$9M
$9M
$8M
Inventory
$339.6K
$339.6K
$2M
$2M
$2M
$2M
$8M
$8M
$7M
$9M
$15M
$18M
$16M
$11M
$9M
$6M
Prepaid Expense
$410.7K
$581.8K
$278.5K
$198.4K
$184.6K
$298.4K
$312.7K
$507.9K
$499.9K
$161.9K
$197.9K
$167.7K
$170.0K
$111.5K
$131.9K
$44.1K
Current Assets
$8M
$7M
$9M
$10M
$10M
$18M
$34M
$49M
$59M
$33M
$37M
$34M
$34M
$28M
$27M
$23M
PP&E (Net)
$376.7K
$403.5K
$430.4K
$457.2K
$523.6K
$591.1K
$158.1K
$221.1K
$291.5K
$361.8K
$432.2K
$502.6K
$573.0K
$643.4K
$747.1K
$887.4K
PP&E (Gross)
$2M
$2M
$2M
$2M
$2M
$2M
$1M
$1M
$1M
$1M
$1M
$1M
$1M
$1M
$1M
$1M
Accum. Depreciation
$1M
$1M
$1M
$1M
$1M
$1M
$930.9K
$868.0K
$797.6K
$727.2K
$656.8K
$586.4K
$516.0K
$445.7K
$342.0K
$201.7K
Goodwill
·
·
$3M
$3M
$3M
$3M
$4M
$4M
$4M
$2M
$2M
$2M
$2M
$2M
$2M
$2M
Intangibles
$655.8K
$819.2K
$982.6K
$1M
$1M
$1M
$2M
$2M
$2M
$2M
$2M
$2M
$3M
$3M
$3M
$3M
Total Assets
$10M
$9M
$14M
$15M
$16M
$24M
$41M
$56M
$70M
$42M
$43M
$40M
$41M
$34M
$33M
$29M
Accounts Payable
·
·
·
·
·
·
·
·
·
·
·
$5M
$7M
·
$14M
$11M
Short-term Debt
·
·
·
·
·
·
·
·
·
·
·
·
$1M
·
·
·
Current Liabilities
$30M
$18M
$18M
$9M
$6M
$6M
$5M
$7M
$9M
$13M
$14M
$18M
$26M
$23M
$27M
$21M
Capital Leases
$40.1K
$99.2K
$157.2K
$198.2K
$259.2K
$319.2K
$13.1K
$317.5K
$342.4K
$356.3K
$367.5K
$378.3K
$389.0K
$399.4K
$409.7K
$419.6K
Total Liabilities
$33M
$24M
$21M
$15M
$8M
$9M
$8M
$10M
$13M
$14M
$19M
$23M
$31M
$29M
$33M
$27M
Long-term Debt
·
$13M
$12M
$10M
$4M
·
$4M
$5M
$5M
·
$5M
$6M
$7M
·
·
·
Total Debt
·
·
·
·
·
·
·
·
·
·
·
·
$1M
·
·
·
Common Stock
$24.9K
$21.9K
$20.8K
$20.4K
$20.4K
$20.4K
$19.9K
$19.4K
$19.4K
$14.4K
$14.3K
$14.3K
$14.2K
$14.1K
$12.5K
$12.3K
Paid-in Capital
$87M
$83M
$78M
$77M
$77M
$77M
$75M
$73M
$70M
$43M
$42M
$42M
$41M
$41M
$39M
$39M
Retained Earnings
$-109M
$-97M
$-83M
$-76M
$-69M
$-61M
$-41M
$-27M
$-14M
$-15M
$-18M
$-25M
$-31M
$-36M
$-39M
$-37M
Treasury Stock
$2M
$2M
$2M
$2M
$632.0K
$632.0K
$485.1K
·
·
·
·
·
·
·
·
·
Stockholders' Equity
$-24M
$-15M
$-6M
$116.1K
$8M
$15M
$33M
$46M
$56M
$28M
$24M
$16M
$10M
$5M
$631.8K
$2M
Liabilities + Equity
$10M
$9M
$14M
$15M
$16M
$24M
$41M
$56M
$70M
$42M
$43M
$40M
$41M
$34M
$33M
$29M
Shares Outstanding
24,190,822
21,151,974
20,065,278
19,735,596
20,068,929
20,068,929
19,650,779
19,431,549
19,431,549
14,403,261
14,343,261
14,234,655
14,176,914
14,116,832
12,348,834
12,348,834
Cash Flow12
Quarterly Cash Flow data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
D&A
$26.8K
$26.8K
$26.8K
$66.4K
$86.1K
$519.6K
$282.1K
$70.4K
$70.4K
$233.8K
$233.8K
$233.8K
$233.8K
$268.9K
$301.9K
$191.6K
Stock-based Comp
·
·
·
$155.1K
·
$2M
·
$3M
$6.2K
$585.9K
$9.3K
$-298.2K
$316.8K
$9.3K
$9.3K
$9.3K
Amort. of Intangibles
$163.4K
$163.5K
$163.4K
$163.5K
$163.5K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
$163.4K
Other Non-cash
$7M
·
·
·
$585.5K
·
·
·
·
·
·
·
·
·
·
·
Operating Cash Flow
$-5M
$-4M
$-5M
$-6M
$-7M
$-8M
$-13M
$-4M
$4M
$2M
$8M
$-3M
$3M
$5M
$-803.0K
$175.5K
CapEx
·
·
·
·
·
·
·
·
·
·
·
·
·
$1.8K
$-1.8K
$0
Investing Cash Flow
·
$0
$0
$0
$-18.6K
$8M
·
·
·
$0
$0
$-124.3K
$-157.0K
$-389.0K
$1.8K
$-1M
Net Debt Issued
·
·
·
·
$-2.8K
·
·
·
$-2.9K
·
·
·
·
·
·
·
Stock Issued
$3M
$1M
·
·
·
$0
$0
$0
$17M
·
·
·
·
·
·
·
Net Stock Activity
$3M
·
·
·
·
·
·
·
$17M
·
·
·
·
·
·
·
Financing Cash Flow
$5M
$3M
$3M
$5M
$-410.5K
$-545.4K
$-873.7K
$-380.3K
$24M
$-67.0K
$-562.3K
$-908.0K
$-882.3K
$-5M
$-11.3K
$6M
Net Change in Cash
$402.9K
$-501.7K
$-2M
$-993.3K
$-7M
$-861.2K
$-25M
$-5M
$28M
$2M
$8M
$-4M
$2M
$-856.4K
$-812.5K
$5M
Profitability7
Quarterly Profitability data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Operating Margin
-70.1%
·
-37.2%
-59.1%
-71.7%
·
·
·
5.6%
·
20.8%
17.3%
13.5%
·
-2.8%
-3.0%
Net Margin
-75.4%
·
-40.1%
-61.5%
-72.2%
·
·
·
3.9%
·
20.7%
16.6%
13.1%
·
-4.3%
-3.5%
Pretax Margin
-75.4%
·
-40.1%
-61.5%
-72.2%
·
·
·
5.2%
·
·
·
·
·
·
·
EBITDA Margin
-69.9%
·
-37.1%
-58.6%
-70.9%
·
·
·
5.6%
·
20.8%
17.3%
13.5%
·
-2.8%
-3.0%
ROA
-95.8%
·
-26.8%
-19.8%
-17.9%
·
-33.7%
-26.7%
2.2%
·
18.5%
17.2%
15.6%
·
-7.3%
-5.3%
ROE
150.9%
·
-55.9%
-30.6%
-23.9%
·
-50.2%
-41.2%
3.7%
·
58.2%
64.6%
74.3%
·
31.1%
27.0%
ROIC
·
·
·
·
·
·
·
-29.4%
2.3%
·
·
·
·
·
·
·
Liquidity & Solvency4
Quarterly Liquidity & Solvency data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Current Ratio
0.3
·
0.5
1.1
1.7
·
6.2
7.4
6.3
·
2.6
1.8
1.3
·
1.0
1.1
Quick Ratio
0.2
·
0.4
0.8
1.4
·
4.6
6.0
5.4
·
1.6
0.8
0.7
·
0.6
0.8
Debt / Equity
·
·
·
·
·
·
·
·
·
·
·
·
0.1
·
·
·
Interest Coverage
·
·
·
·
·
·
·
·
·
·
·
·
11.8
·
·
·
Efficiency3
Quarterly Efficiency data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Asset Turnover
1.3
·
0.7
0.3
0.2
·
·
·
0.6
·
0.9
1.0
1.2
·
1.7
1.5
Inventory Turnover
22.3
·
4.1
2.6
3.0
·
1.1
1.4
2.0
·
2.0
2.2
2.9
·
6.9
8.8
Receivables Turnover
4.2
·
6.4
5.6
2.0
·
·
·
3.5
·
3.6
3.9
4.5
·
6.5
6.3
Per Share5
Quarterly Per Share data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Book Value / Share
$-0.98
·
$-0.32
$0.01
$0.39
·
$1.69
$2.38
$2.88
·
$1.65
$1.15
$0.70
·
$0.05
$0.17
Revenue / Share
$0.67
·
$0.94
$0.58
$0.53
·
·
·
$1.68
·
$2.35
$2.38
$2.39
·
·
·
Cash Flow / Share
$-0.19
·
·
·
$-0.35
·
·
·
$0.22
·
·
·
$0.20
·
·
·
Cash / Share
$0.08
·
$0.13
$0.22
$0.27
·
$0.69
$1.98
$2.21
·
$0.89
$0.36
$0.63
·
$0.64
$0.70
EPS (TTM)
$-1.63
·
$-1.85
$-2.13
$-1.70
·
$-0.83
$0.30
$1.27
·
$1.08
$0.51
$0.01
·
·
·
Valuation (TTM)12
Quarterly Valuation (TTM) data for SURG
Metric
Trend
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Revenue TTM
$57M
·
$46M
$42M
$62M
·
$85M
$117M
$136M
·
$141M
$135M
$120M
·
$100M
$75M
Net Income TTM
$-34M
·
$-36M
$-42M
$-34M
·
$-19M
$1M
$19M
·
$16M
$8M
$820.8K
·
$-5M
$-4M
Market Cap
$18M
·
$56M
$61M
$42M
·
$36M
$62M
$75M
·
$67M
$104M
$64M
·
$56M
$60M
Enterprise Value
·
·
·
·
·
·
·
·
·
·
·
·
$56M
·
·
·
P/E
-0.5
·
-1.5
-1.5
-1.2
·
-2.2
10.6
3.0
·
4.3
14.3
449.0
·
·
·
P/S
0.3
·
1.2
1.5
0.7
·
0.4
0.5
0.5
·
0.5
0.8
0.5
·
0.6
0.8
P/B
-0.8
·
-8.9
528.6
5.3
·
1.1
1.3
1.3
·
2.8
6.4
6.5
·
88.9
28.1
P / Tangible Book
·
·
·
·
12.9
·
1.3
1.5
1.5
·
3.4
8.5
11.4
·
·
·
P / Cash Flow
-4.0
·
·
·
-6.0
·
·
·
18.5
·
·
·
22.2
·
·
·
EV / EBITDA
·
·
·
·
·
·
·
·
·
·
·
·
11.9
·
·
·
EV / Revenue
·
·
·
·
·
·
·
·
·
·
·
·
0.5
·
·
·
Earnings Yield
-217.0%
·
-65.8%
-68.5%
-82.1%
·
-45.1%
9.4%
33.0%
·
23.1%
7.0%
0.22%
·
·
·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$57M
$61M
$137M
$122M
$51M
Operating Margin %
-59.9%
-68.6%
13.8%
0.52%
-11.7%
Net Income
$-36M
$-46M
$21M
$-680.8K
$-14M
Diluted EPS
$-1.80
$-2.39
$1.38
$-0.05
—
Balance Sheet
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Debt / Equity
—
—
—
—
0.0
Current Ratio
0.4
2.9
2.6
1.2
1.4
Quick Ratio
0.3
2.4
1.9
0.7
1.0
Cash Flow
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$-21M
$-22M
—
$781.9K
$-15M
My Metrics
Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F)
41 filers · $2.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
13
(+4 vs prior Q)
5
(+1 vs prior Q)
6
(-1 vs prior Q)
4
(+1 vs prior Q)
+210K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners
2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership
Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.